Christina Ciaccio to Peanut Hypersensitivity
This is a "connection" page, showing publications Christina Ciaccio has written about Peanut Hypersensitivity.
Connection Strength
3.003
-
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 Dec; 129(6):758-768.e4.
Score: 0.854
-
Food OIT: What do we know, what don't we know, and what do we need to know? Ann Allergy Asthma Immunol. 2019 08; 123(2):118-119.
Score: 0.692
-
Ara h2 levels in dust from homes of individuals with peanut allergy and individuals with peanut tolerance. Allergy Asthma Proc. 2017 May 01; 38(3):192-196.
Score: 0.592
-
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
Score: 0.225
-
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. J Allergy Clin Immunol Pract. 2021 05; 9(5):1879-1889.e13.
Score: 0.191
-
Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology. J Allergy Clin Immunol Pract. 2019 02; 7(2):721-723.e9.
Score: 0.166
-
AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med. 2018 Nov 22; 379(21):1991-2001.
Score: 0.165
-
Effect of maternal ?3 fatty acid supplementation on infant allergy. Ann Allergy Asthma Immunol. 2014 Mar; 112(3):191-4.
Score: 0.119